Mereo BioPharma Group plc announced the appointment of Anne Hyland to the Company's Board of Directors, effective immediately. Ms. Hyland has also been appointed to serve on the Audit and Risk Committee of the Board. Ms. Hyland joins Mereo's Board with over 30 years of financial experience in both private and public companies in the biopharmaceutical space.

Ms. Hyland is a non-executive director and Chair of the Audit and Risk Committee of Clinigen Group plc. She is also Chair of the Audit Committee and a non-executive director of Elementis plc, a global specialty chemicals company. Ms. Hyland was Chief Financial Officer (CFO) and Company Secretary of Kymab Group Limited.